Omeprazolo Zentiva Italia (Omeprazole)

Omeprazole, the active ingredient in Omeprazolo Zentiva Italia, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat acid‑related conditions such as gastro‑esophageal reflux disease and peptic ulcers in adult patients. It is indicated for the management of acid hypersecretion disorders and is commonly prescribed in both outpatient and inpatient settings.

GNH USA supplies Omeprazolo Zentiva Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, providing reliable sourcing and regulatory support for global healthcare providers.

Omeprazole, a proton pump inhibitor, is used to treat several acid‑related gastrointestinal conditions. - Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic therapy by suppressing acid production. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Omeprazole may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools often transient. - Nausea: feeling of sickness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased gas. - Vomiting: occasional expulsion of stomach contents. Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: severe diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash. - Hepatic enzyme elevation: increased liver function tests.

When prescribing Omeprazole, several precautions should be considered to ensure safe use. - Assess renal and hepatic function: dose adjustment may be needed in impairment. - Evaluate for Helicobacter pylori infection: appropriate testing before initiating therapy. - Monitor long‑term use: prolonged therapy may increase risk of fractures and vitamin B12 deficiency. - Review concomitant medications: potential interactions with drugs requiring acidic environment. - Use in pregnancy and lactation: only if benefits outweigh risks, as data are limited. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines, requiring attention to possible interactions. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir or other protease inhibitors: decreased absorption and efficacy. - Methotrexate (high dose): increased toxicity due to reduced renal clearance. - Warfarin: enhanced anticoagulant effect, risk of bleeding. Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels. - Iron supplements: reduced absorption, separate dosing by at least 2 hours. - Vitamin B12: decreased absorption with long‑term use. - Diazepam: possible increased sedation.